Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 3 trial of ponatinib, its investigational pan-BCR-ABL inhibitor, in adult patients with newly diagnosed chronic myeloid leukemia (CML).

28 Jul 2012

Five physicians receive ASTRO research grants to promote advancement of radiation therapy

The American Society for Radiation Oncology (ASTRO) has awarded five physicians with research grants to promote the continued advancement of radiation therapy-the Junior Faculty Career Research Training Award and the Residents/Fellows in Radiation Oncology Research Seed Grant Award. Recipients were selected by ASTRO's Research Evaluation Committee.

28 Jul 2012

Oximetry detects sleep disorder in stroke patients

Nocturnal oximetry is an accurate instrument for detecting and diagnosing sleep apnea syndrome in patients with stroke, research indicates.

27 Jul 2012

Rehab benefit for meth abuse not crystal clear

Community-based residential rehabilitation significantly reduces methamphetamine use compared with detoxification, but the effect only lasts for up to a year, researchers report.

27 Jul 2012

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

TB is a leading global killer. It is the second leading infectious disease in the world, behind HIV. TB is spread through the air, so it can affect anyone, but has its worst impact on impoverished communities and those people with HIV.

27 Jul 2012

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.

27 Jul 2012

High-dose IL-2 still the most effective treatment for patients with stage IV metastatic melanoma

Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.

26 Jul 2012

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2012.

26 Jul 2012

Short-course palliative RT shows promise

A 2-day course of three-dimensional radiotherapy delivered in twice-daily fractions up to 18 Gy resulted in no dose-limiting toxicities, and high rates of symptom relief in patient with pelvic cancer, especially those with bleeding, report researchers.

26 Jul 2012

Walking speeds the way to understanding elderly blood pressure

The first study to examine walking speed, mortality, and blood pressure has shown that frail, elderly adults who have high blood pressure may actually be at a decreased risk for mortality, write researchers in the Archives of Internal Medicine.

26 Jul 2012

Visual impairment hampers elderly patients’ self-management

Elderly patients with visual impairment need extra support to help them manage their medications, report UK researchers.

26 Jul 2012

Virginia Hospital Center offers new Calypso System for patients with prostate cancer

Virginia Hospital Center is among the few hospitals along the east coast to offer the new Calypso® System featuring GPS for the Body technology and Beacon electromagnetic transponders for patients with certain types of cancer.

26 Jul 2012

Bard completes enrollment in Lutonix DCB clinical trial for peripheral arterial disease

C. R. Bard, Inc. today announced that its Lutonix technology center completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial.

26 Jul 2012

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.

26 Jul 2012

Miriam researchers encourage physicians to inquire about ED symptoms in young, middle-aged men

Although erectile dysfunction (ED) has been shown to be an early warning sign for heart disease, some physicians - and patients - still think of it as just as a natural part of "old age." But now an international team of researchers, led by physicians at The Miriam Hospital, say it's time to expand ED symptom screening to include younger and middle-aged men.

26 Jul 2012

Roche Diabetes Care announces availability of new ACCU-CHEK Nano SmartView System

Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce the availability of the new, user-friendly ACCU-CHEK Nano SmartView System.

26 Jul 2012

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and to evaluate preliminary efficacy of aldoxorubicin (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors who have failed other therapies.

26 Jul 2012

Oncology News and Research

Further Reading

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

Five physicians receive ASTRO research grants to promote advancement of radiation therapy

Oximetry detects sleep disorder in stroke patients

Rehab benefit for meth abuse not crystal clear

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

High-dose IL-2 still the most effective treatment for patients with stage IV metastatic melanoma

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Short-course palliative RT shows promise

Walking speeds the way to understanding elderly blood pressure

Visual impairment hampers elderly patients’ self-management

Virginia Hospital Center offers new Calypso System for patients with prostate cancer

Bard completes enrollment in Lutonix DCB clinical trial for peripheral arterial disease

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

Miriam researchers encourage physicians to inquire about ED symptoms in young, middle-aged men

Roche Diabetes Care announces availability of new ACCU-CHEK Nano SmartView System

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

Malaria commonly misdiagnosed and mistreated in Afghanistan

Self-neglect predicts hospice use among elderly

Cepheid launches new Xpert BCR-ABL Monitor test

Industry Focus eBook - Oncology (3rd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News